Clinical Trials Logo

Clinical Trial Summary

Assess the impact of chronic use of aspartame on glycemia, appetite and body composition.

Clinical Trial Description

Participants will be randomly assigned to one of three parallel arms: 0% (water), 5 mg, 15mg aspartame. Participants will have an oral glucose tolerance test at the beginning and end of a 12 week intervention. . Participants will report to the lab weekly for 12 weeks to pick up their next week's intervention products and measurements for body weight, waist circumference, blood pressure and heart rate. They will consume their intervention products daily for 12 weeks. They will record appetite sensations and collect a 24 hour urine sample at weeks 0, 4, 8, and 12. ;

Study Design

Related Conditions & MeSH terms

NCT number NCT02999321
Study type Interventional
Source Purdue University
Status Completed
Phase N/A
Start date August 17, 2016
Completion date May 5, 2017

See also
  Status Clinical Trial Phase
Completed NCT02417519 - Coffee Roasting and Glucose Tolerance N/A